How much does a box of lapatinib cost?

Lapatinib (Lapatinib) is an oral molecularly targeted drug widely used to treat breast cancer. It is a tyrosine kinase inhibitor that prevents the growth and spread of cancer cells by inhibiting receptor tyrosine kinase (RTK). The development and application of lapatinib brings new hope to breast cancer patients, especially those who are resistant to traditional treatments.

Lapatinib is already on the market in China, but it has not yet been included in medical insurance. Patients can purchase it domestically at a price of around 5,000 to 6,000 yuan. Please consult the local hospital pharmacy for specific prices. There are original lapatinib drugs and generic drugs abroad. The original drug is cheaper than the original drug in Türkiye, which costs more than 2,000 yuan. Generic drugs include Indian generic drugs and Bangladeshi generic drugs, and the price is around a few hundred yuan. The ingredients of domestic original drugs, foreign original drugs and generic drugs are basically the same.

The mechanism of action of lapatinib is to prevent the proliferation and survival of cancer cells by simultaneously inhibiting the activity of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2). These two receptors play a key role in the development of breast cancer, especially HER2-positive breast cancer, so lapatinib is particularly effective in these patients.

Lapatinib is often given in combination with other treatments such as radiation, chemotherapy, or hormonal therapy to increase its effectiveness. It can be used as first-line treatment, second-line treatment, or in the treatment of advanced breast cancer, and specific use will be based on the patient's condition and the recommendations of the clinician.

Although lapatinib has made significant progress in the treatment of breast cancer, it may also cause some side effects, such as diarrhea, rash, fatigue, and hand-foot syndrome. Therefore, when using lapatinib, doctors will monitor and manage the patient on a case-by-case basis.